Unravelling neurotransmitters impairment in primary progressive aphasias
- PMID: 36649260
- PMCID: PMC10028634
- DOI: 10.1002/hbm.26206
Unravelling neurotransmitters impairment in primary progressive aphasias
Abstract
Primary progressive aphasias (PPAs) are a group of neurodegenerative diseases mainly characterized by language impairment, and with variably presence of dysexecutive syndrome, behavioural disturbances and parkinsonism. Detailed knowledge of neurotransmitters impairment and its association with clinical features hold the potential to develop new tailored therapeutic approaches. In the present study, we applied JuSpace toolbox, which allowed for cross-modal correlation of magnetic resonance imaging (MRI)-based measures with nuclear imaging derived estimates covering various neurotransmitter systems including dopaminergic, serotonergic, noradrenergic, GABAergic and glutamatergic neurotransmission. We included 103 PPA patients and 80 age-matched healthy controls (HC). We tested if the spatial patterns of grey matter volume (GMV) alterations in PPA patients (relative to HC) are correlated with specific neurotransmitter systems. As compared to HC, voxel-based brain changes in PPA were significantly associated with spatial distribution of serotonin, dopamine, and glutamatergic pathways (p < .05, False Discovery Rate corrected-corrected). Disease severity was negatively correlated with the strength of GMV colocalization of D1 receptors (p = .035) and serotonin transporter (p = .020). Moreover, we observed a significant negative correlation between positive behavioural symptoms, as measured with Frontal Behavioural Inventory, and GMV colocalization of D1 receptors (p = .007) and serotonin transporter (p < .001). This pilot study suggests that JuSpace is a helpful tool to indirectly assess neurotransmitter deficits in neurodegenerative dementias and may provide novel insight into disease mechanisms and associated clinical features.
Keywords: behavioural disturbances; magnetic resonance imaging; neurotransmitters; positron emission tomography; primary progressive aphasia.
© 2023 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.
Conflict of interest statement
No competing interests were disclosed.
Figures



References
-
- Benussi, A. , Dell'Era, V. , Cantoni, V. , Cotelli, M. S. , Cosseddu, M. , Spallazzi, M. , Micheli, A. , Turrone, R. , Alberici, A. , & Borroni, B. (2020). TMS for staging and predicting functional decline in frontotemporal dementia. Brain Stimulation, 13, 386–392. - PubMed
-
- Benussi, A. , Dell'Era, V. , Cosseddu, M. , Cantoni, V. , Cotelli, M. S. , Cotelli, M. , Manenti, R. , Benussi, L. , Brattini, C. , Alberici, A. , & Borroni, B. (2020). Transcranial stimulation in frontotemporal dementia: A randomized, double‐blind, sham‐controlled trial. Alzheimer's Dement (New York, NY), 6, 1–11. - PMC - PubMed
-
- Benussi, A. , Di Lorenzo, F. , Dell'Era, V. , Cosseddu, M. , Alberici, A. , Caratozzolo, S. , Cotelli, M. S. , Micheli, A. , Rozzini, L. , Depari, A. , Flammini, A. , Ponzo, V. , Martorana, A. , Caltagirone, C. , Padovani, A. , Koch, G. , & Borroni, B. (2017). Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia. Neurology, 89, 665–672. - PubMed
-
- Benussi, A. , Grassi, M. , Palluzzi, F. , Koch, G. , Di Lazzaro, V. , Nardone, R. , Cantoni, V. , Dell'Era, V. , Premi, E. , Martorana, A. , di Lorenzo, F. , Bonnì, S. , Ranieri, F. , Capone, F. , Musumeci, G. , Cotelli, M. S. , Padovani, A. , & Borroni, B. (2020). Classification accuracy of transcranial magnetic stimulation for the diagnosis of neurodegenerative dementias. Annals of Neurology, 87, 394–404. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials